Fibonacci acquires, develops, and transacts drugs. Two AI-native systems work in concert to 10x scientific impact.
Buy & build drugs
AI-native drug hunting scaled across all drugs and diseases
Run trials as efficiently as possible
AI-native development with operational efficiency and excellence
Intelligence is becoming a commodity — now is the time to rebuild the drug development OS.
The Iron Man Suit for Drug Hunters
The always-on drug hunter. Months of diligence compressed to days. Focusing on best-in-class or first-in-class opportunities across every therapeutic area.
Drug Profile Design
Comparator-anchored TPP specs, differentiation theses, and evidence maps for every candidate.
Competitive Intelligence
Landscape grids, unmet needs analysis, and positioning maps generated continuously across all indications.
Clinical Blueprints
Trial design, endpoints, budget models, and go/no-go packages — ready before the asset is acquired.
The Claude Code for Drug Development
AI-native clinical development with zero latency response times. Program design in minutes, not months. Real-time learning and updates to plans.
Program Design in Minutes
Instant cascade of decisions and protocol updates across the entire development program.
Consolidated Cross-Org View
Single source of truth across clinical, regulatory, CMC, and operations — no more siloed CROs.
Real-Time Learning
Every clinical action refines the automated workflows and deliverables. The system improves with every program.
Every Program Compounds the Advantage
Four dimensions multiply with each cycle. Fibonacci scales with programs, not headcount.
Define and evaluate opportunities
Every TPP improves our ability to identify and assess drug candidates.
Automated processes and outputs
Every clinical action refines the automated workflows and deliverables.
The I/O interface for agents
Each CRO and CMC interaction creates structured interfaces for AI agents.
Network of experts and knowledge
Every program and phase expands our pool of domain experts and knowledge.
These dimensions don't add — they multiply.
More data → better automation → faster cycles → more programs → more data. The moat compounds with every drug.
Operating Model Architecture
The Asset Foundry
Buy & build drugs
The Refinery
Run trials efficiently
Intelligence scales through AI — the same number of FTEs required for 3 vs 30 drugs.